FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
International Consolidated Airlines Group (LON:IAG) has reached agreement with Boeing to order 25 737-8200 and 25 737-10 aircraft, plus 100 options. The aircraft will be delivered between 2023 and 2027..
British Land Company PLC (LON:BLND) has announced its full year results. Performance summary £2.2bn capital activity – actively recycling capital into areas of growth and value – £694m from the sale..
Burberry Group plc (LON:BRBY) has announced its preliminary results for 53 weeks ended 2 April 2022. “Burberry is a unique British company with an extraordinary history and heritage and it..
Vodafone Group Plc (LON:VOD) has announced its FY22 Preliminary results. Good financial performance with growth in revenues, profits and cash flows · Good service revenue growth in FY22 with continued growth..
DCC plc (LON:DCC), the leading international sales, marketing and support services group, is hosting an event for market participants today at 1.00 p.m. BST, 17 May 2022. The event will..
Experian plc (LON:EXPN), the global information services company, has announced that it has agreed to acquire MOVA Sociedade de Empréstimo entre Pessoas S.A., a leading fintech in Brazil that helps..
Vodafone Group Plc (LON:VOD) has announced that Stephen Carter will be appointed as a non-executive director following the Company’s Annual General Meeting on 26 July 2022, subject to shareholder approval...
BT Group plc (LON:BT.A) has agreed a set of definitive agreements with Warner Bros. Discovery Inc (NASDAQ:WBD) to form a 50:50 joint venture company to create a new premium sport..
Compass Group plc (LON:CPG) has announced its half year results announcement for the six months ended 31 March 2022. Underlying1 results HY 2022 Underlying1 results HY 2021 Underlying1 results Change..
ITV plc (LON:ITV) has announced its Q1 Trading Update for the 3 months to 31 March 2022. Carolyn McCall, ITV Chief Executive, said: “ITV has achieved strong Q1 revenues driven..
After over 16 Years with Rightmove plc (LON:RMV), Peter Brooks-Johnson, the CEO, has made the decision to step down from the Board and leave the Company in the coming year...
Ocado Group plc (LON:OCDO) will be hosting a meeting to discuss modelling of Ocado Group and the underlying operating segments on Wednesday 25th May 2022 at 3pm. Stephen Daintith, CFO,..
Barratt Developments PLC (LON:BDEV) has issued a trading update in respect of the period from 1 January 2022 to 1 May 2022. Comparatives are to the prior year equivalent period..
Shell plc (LON:SHEL) has announced an interim dividend in respect of the first quarter of 2022 of US$ 0.25 per ordinary share. Details relating to the first quarter 2022 interim..
Flutter Entertainment plc (LON:FLTR) has announced a trading update for three months ended 31 March 2022. Unaudited £m Q1 2022 Q1 2021 YoY % YoY % CC1 Average monthly players2 (‘000s) 8,855 7,672..
AstraZeneca plc (LON:AZN) supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally..
Avast plc (LON:AVST), together with its subsidiaries, a leading global cybersecurity provider, has issued the following scheduled trading update for the first quarter of its current financial year, comprising the..
NatWest Group plc (LON:NWG) has announced its Q1 2022 Interim Management Statement. Chief Executive, Alison Rose, commented: “The world has changed considerably during the last three months. Our thoughts are..
AstraZeneca PLC (LON:AZN) has announced its first quarter 2022 results. Revenue and EPS summary Q1 2022 % Change $m Actual CER1 – Product Sales ..
AstraZeneca plc (LON:AZN) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of adult patients with unresectable or metastatic HER2-low..
